Some biomedical researchers may be unsure about routine electronic health record (EHR) data and how useful it ultimately may prove for drawing meaningful, actionable associations that warrant changes to clinical practice and lead to improved clinical outcomes.

Using data from the UK Biobank and Vanderbilt’s BioVU, a new study in the journal Molecular Psychiatry finds that approximately 4 percent of suicide attempt risk is captured by genotype data.

Around two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, will be advised to undergo hormone therapy for five to 10 years to prevent recurrence.

When clinical teams at Vanderbilt University Medical Center dramatically reduced several types of preoperative testing for elective surgery patients, there were no repercussions for these patients in terms of case cancellation rates, average length of stay in the hospital or rates of readmission to VUMC.

The Mid-South Clinical Data Research Network, led by Vanderbilt University Medical Center’s Russell Rothman, MD, MPP, is a collaborative effort among a group of large health care systems to support and conduct innovative comparative effectiveness research and clinical trials.

A research team led by Vanderbilt University Medical Center’s Russell Rothman, MD, MPP, has been approved for a $7 million research funding award from the Patient-Centered Outcomes Research Institute (PCORI) to conduct a randomized, multi-center trial comparing clinic and consumer information technology approaches to promote healthy behaviors and prevent early childhood obesity.